Investors in Globus Medical, Inc. GMED need to pay close attention to the stock based on moves in the options market ... a big move in one direction or the other. It could also mean there is an event ...

RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Globus Medical (GMED – Research Report) yesterday and set a price target of ...

StockNews.com lowered shares of Globus Medical (NYSE:GMED – Free Report) from a buy rating to a hold rating in a research ...

Price Targets: Delving into movements, analysts provide estimates for the future value of Globus Medical's stock. This analysis reveals shifts in analysts' expectations over time. Considering ...

Globus Medical, Inc. GMED reported fourth-quarter ... Following the earnings announcement, GMED stock dropped 0.3% in after-market trading yesterday. Net sales generated in the United States ...

NYSE GMED opened at $83.99 on Friday. Globus Medical has a fifty-two week low of $49.33 and a fifty-two week high of $94.93. The stock has a market cap of $11.44 billion, a PE ratio of 125.36, a P ...

In November, I believed that shares of Globus Medical (NYSE:GMED ... as shares fell to the $60 mark upon the announcement of the stock transaction, as the market was skeptic about the deal.

Welcome to the Globus Medical's fourth quarter and full year 2024 earnings call. At this time, all lines will be on mute, and a Q&A session will be held after the prepared remarks. I will now turn ...

Currently, Globus Medical has a market capitalization of $11.28 billion. Buying $1000 In GMED: If an investor had bought $1000 of GMED stock 10 years ago, it would be worth $3,281.90 today based ...

Options with high levels of implied volatility suggest that investors in the underlying stocks ... feel about Globus Medical right now, this huge implied volatility could mean there’s a trade ...